TH137273A - Polyhedron, crystalline and isophase form of sodium. 2- (5-bromo-4- (4-cyclopropyl naphthalane-1-il) -4H-1,2,4-triazol-3-ilthio) Acetates and their applications - Google Patents
Polyhedron, crystalline and isophase form of sodium. 2- (5-bromo-4- (4-cyclopropyl naphthalane-1-il) -4H-1,2,4-triazol-3-ilthio) Acetates and their applicationsInfo
- Publication number
- TH137273A TH137273A TH1201003405A TH1201003405A TH137273A TH 137273 A TH137273 A TH 137273A TH 1201003405 A TH1201003405 A TH 1201003405A TH 1201003405 A TH1201003405 A TH 1201003405A TH 137273 A TH137273 A TH 137273A
- Authority
- TH
- Thailand
- Prior art keywords
- triazol
- bromo
- sodium
- ilthio
- naphthalane
- Prior art date
Links
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 title claims abstract 5
- 229910052708 sodium Inorganic materials 0.000 title claims abstract 5
- 239000011734 sodium Substances 0.000 title claims abstract 5
- 150000001242 acetic acid derivatives Chemical class 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims abstract 4
- 201000010099 disease Diseases 0.000 claims abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 4
- FVYMVLTWIBGEMC-UHFFFAOYSA-M sodium;2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetate Chemical compound [Na+].[O-]C(=O)CSC1=NN=C(Br)N1C(C1=CC=CC=C11)=CC=C1C1CC1 FVYMVLTWIBGEMC-UHFFFAOYSA-M 0.000 claims abstract 4
- 239000007787 solid Substances 0.000 claims abstract 4
- 239000000470 constituent Substances 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 1
Abstract
DC60 (06/07/55) รูปแบบพหุสัญฐานที่เป็นผลึก (Crystalline polymorphs) และรูปแบบมีโซเฟสที่เป็น ของแข็ง (solid mesophase) ของโซเดียม 2-(5-โบรโม-4-(4-ไซโคลโพรพิลแนฟธาเลน-1-อิล)-4H-1,2,4- ไตรอะซอล-3-อิลไธโอ)อะซิเตต (sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4- triazol-3-ylthio)acetate) จะถูกอธิบายไว้ นอกจากนี้, องค์ประกอบเชิงเภสัชกรรมและการใช้งานของ องค์ประกอบดังกล่าวสำหรับการบำบัดโรคและสภาวะต่างๆ จะถูกให้ไว้ รูปแบบพหุสัญฐานที่เป็นผลึก (Crystalline polymorphs) และรูปแบบมีโซเฟสที่เป็น ของแข็ง (solid mesophase) ของโซเดียม 2-(5-โบรโม-4-(4-ไซโคลโพรพิลแนฟธาเลน-1-อิล)-4H-1,2,4- ไตรอะซอล-3-อิลไธโอ)อะซิเตต (sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4- triazol-3-ylthio)acetate) จะถูกอธิบายไว้ นอกจากนี้, องค์ประกอบเชิงเภสัชกรรมและการใช้งานของ องค์ประกอบดังกล่าวสำหรับการบำบัดโรคและสภาวะต่างๆ จะถูกให้ไว้ สิทธิบัตรยา DC60 (06/07/55) Crystalline polymorphs and solid mesophase form of sodium 2- (5-bromo-4- (4-) Cyclopropyl naphthalane-1-il) -4H-1,2,4-triazol-3-ilthio) acetate (sodium 2- (5-bromo-4 - (4-cyclopropylnaphthalen-1-yl) -4H-1,2,4- triazol-3-ylthio) acetate) is described. In addition, the pharmaceutical composition and usage of The constituents for the treatment of diseases and conditions are given Crystalline polymorphs and solid mesophase forms of sodium 2- (5-bromo). -4- (4-cyclopropyl naphthalane-1-il) -4H-1,2,4-triazol-3-ilthio) acetate (sodium 2- (5-bromo-4- (4-cyclopropylnaphthalen-1-yl) -4H-1,2,4- triazol-3-ylthio) acetate) is described. In addition, the Pharmaceutical Composition and Use of Such elements for the treatment of diseases and conditions are patented drug.
Claims (1)
Publications (2)
Publication Number | Publication Date |
---|---|
TH137273B TH137273B (en) | 2014-10-09 |
TH137273A true TH137273A (en) | 2014-10-09 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201270676A1 (en) | POLYMORPHIC, CRYSTAL AND MESOPHASE FORMS OF 2- (5-BROM-4- (4-CYCLOPROPYLNAFTALINYL-1-IL) -4N-1,2,4-TRIAZOL-3-ILTIO) SODIUM ACETATE AND THEIR USE | |
EP3181559B8 (en) | 2-(2,4,5-substituted aniline) pyrimidine derivative, pharmaceutical composition and use thereof | |
EA201370150A1 (en) | POLYMORPHIC FORMS 2- (5-BROM-4- (4-CYCLOPROPILNAFTALIN-1-IL) -4H-1,2,4-TRIAZOL-3-ILTIO) ACETIC ACID AND THEIR APPLICATION | |
JP2015078230A5 (en) | ||
JP2014221779A5 (en) | ||
BRPI0807907A2 (en) | cocrystals and pharmaceutical compositions comprising them. | |
HK1247201A1 (en) | Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof | |
CL2015002606A1 (en) | Compound. | |
EP2560642A4 (en) | Treatment of gout | |
IL256237A (en) | Solid forms of (z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid | |
BR112018004065A2 (en) | HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUNDS AND THERAPEUTIC USES THEREOF | |
FR3022462B1 (en) | ORAL COMPOSITION OF ANTI-TNFALPHA ANTIBODY | |
CL2013000929A1 (en) | Crystalline form c of the sodium salt of the acid (4- (4- (5- (6-trifluoro methyl pyridin-3-yl-amino) pyridin-2-yl-) phenyl) -cyclohexyl) -acetic acid; Preparation process; pharmaceutical composition that includes it; and its use for the treatment of a disorder associated with the activity of dagt. | |
IL263786B (en) | Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparation | |
EP3339306A4 (en) | Novel crystal form of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxole-5-yl)cyclopropane formamido)-3-methylpyridine-2-yl)benzoic acid and preparation method thereof | |
TH137273A (en) | Polyhedron, crystalline and isophase form of sodium. 2- (5-bromo-4- (4-cyclopropyl naphthalane-1-il) -4H-1,2,4-triazol-3-ilthio) Acetates and their applications | |
DK3619199T3 (en) | PREPARATION OF 2 - ([1,2,3] TRIAZOL-2-YL) -BENZOIC ACID DERIVATIVES | |
TR201910310T4 (en) | Composition containing bee products. | |
RU2015131665A (en) | Alpha-Amylase Inhibitor | |
TH1701002157A (en) | Crystal form of 5- Chloro-N4- [2- (dimethylphosphoril) phenyl] -N2- {2-moxy-4- [4- (4-methyl Piperacin-1-il) Piperidin-1-il] pyrimidin-2,4-diamine | |
TH147910A (en) | Crystalline form of succinate salt | |
CN302203762S (en) | Tunnel drying furnace (1) | |
CN301719935S (en) | Brooch (L00089) | |
MA44264A (en) | ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN | |
PL395739A1 (en) | New medical use of 5- (3-chlorophenyl) -4-ethyl-2,4-dihydro-3H-1,2,4-triazole-3-thion substance |